Current Study: E3

Purpose:
• To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with kidney impairment when compared to volunteers with a normal level of kidney function.
• Information regarding safety and side effects that may occur will also be collected.
• This study is for research purposes only and is not intended to treat your kidney disease.

Method of Administration: Single intravenous (IV) dose of study medication

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 70 years old
• Must have stable kidney impairment or disease
• May be seeing a nephrologist, have reduced kidney function, or low creatinine clearance and taking medicine such as:

• Procrit®, Epogen®, or Aranesp® for low blood count
or
• PhosLo for high blood phosphorus

Length/Duration
9 days, 8 nights in our research facility and 2 follow-up visits

Location: 5055 South Orange Avenue, Orlando, FL 32809

Compensation Qualified participants will receive study medication, study related physical exams and laboratory tests

Qualified participants will be compensated up to $3,700 for time and travel

Whom to Contact Recruitment Department: 407-240-7876